Sitemap

Categories & pages

• Current Clinical Trials
• Anti-ICOS, MEDI-570, PTCL, AITL, Clinical Trials
• Brentuximab Vedotin, CD30 Low, MTCL, Clinical Trials
• Brentuximab Vedotin, CD30-Positive, Clinical Trials
• Brentuximab Vedotin, Clinical Trials, CD30+ Lymphoma
• Carfilzomib with, without Romidepsin, Clinical Trials
• Carfilzomib, Romidepsin, CTCL, Clinical Trials
• Carfilzomib, Romidepsin, Lenalidomide, Clinical Trials
• CC486-CHOP, Clinical Trials, Previously Untreated PTCL
• Copanlisib (BAY80-6946), Clinical Trials, Non-Hodgkin
• CPI-613, Bendamustine Hydrochloride, Clinical Trials
• Doxycycline, Clinical Trials, CTCL
• Duvelisib, Romidepsin, Bortezomib, Clinical Trials
• EDO-S101, HDACi Fusion, Clinical Trials, T-Cell Lymphoma
• FLASH, Synthetic Hypericin, Clinical Trials, CTCL
• Folotyn, Leucovorin, Clinical Trials,
• Ibrutinib, non-Hodgkin, Clinical Trials, T-Cell Lymphoma
• Istodax, Doxil, CTCL, Clinical Trials, T-Cell Lymphoma
• IV Fenretinide, Clinical Trials, T-Cell Lymphoma
• KW-0761, Clinical Trials, Adult T-Cell Lymphoma
• KW-0761, Vorinistat, Clinical Trials, T-Cell Lymphoma
• Lenalidomide, PTCL, Clinical Trials, T-Cell Lymphoma
• MK-3475, Relapsed, Refractory, Phase 2, Clinical Trials
• MNA-D, CTCL, Clinical Trials, T-Cell Lymphoma
• Monoclonal Antibody Therapy, Clinical Trials
• MRG-106, CTCL, Clinical Trials, T-Cell Lymphoma
• Nivolumab with S.O.C, Clinical Trials, PTCL
• Nivolumab, Cabiralizumab, Clinical Trials, PTCL
• Nivolumab, Clinical Trials, Relapsed/Refractory PTCL
• Panobinostat, Clinical Trials, Non-Hodgkin Lymphoma
• PCTL, Cutaneous T-Cell Lymphoma, E7777, Clinical Trials
• Pembrolizumab and Pralatrexate, Clinical Trials, Relapsed/Refractory PTCL
• Pembrolizumab and Romidepsin, Clinical Trials,
• Pralatrexate, Romidepsin, PTCL, Clinical Trials
• Romidepsin CHOP, Clinical Trials, T-Cell Lymphoma
• Romidepsin, Lenalidomide, PTCL, CHOP, Clinical Trials
• Romidepsin, Oral 5 Azacitidine, TCLL, Clinical Trials
• Ruxolitinib Phosphate, Clinical Trials, T-Cell Lymphoma
• Ruxolitinib Phosphate, PTCL, INCB18424, Clinical Trials
• SGN-35 in CD30-Positive ALCL, Clinical Trials
• Tipifarnib, PTCL, Clinical Trials, T-Cell Lymphoma
• Resources & Support
• For Caregivers
• Patient Assistance
• Resources
• Treatment Centers

• About Us
• Donate
• Newsletter Signup
• Partners
• Patient Stories
• Privacy Policy
• Specialist Directory
• Styles Guide
• T-Cell Leukemia Lymphoma Foundation

Forms

• Contact Us
• Event and Newsletter Sign Up
• Volunteer

News & Events

• Learning Corner
• Blog
• Learning Corner

Products

• Become a Sponsor
• Bronze Sponsorship
• Gold Sponsorship
• Platinum Sponsorship
• Silver Sponsorship

Services

• For Patients
  • What is TCLL?
  • Diagnosis & Pathology
    • How a Diagnosis of T Cell or NK Cell Leukemia/Lymphoma is Made: T-Cell Pathology Dictionary
    • How a Diagnosis of T Cell or NK Cell Leukemia/Lymphoma is Made: General Overview of PTCL Diagnosis
    • How a Diagnosis of T Cell or NK Cell Leukemia/Lymphoma is Made: Evaluation of Biopsy Specimen
  • Subtypes
    • Peripheral T-cell Lymphoma, Not Otherwise Specified - PTCL-NOS
    • Anaplastic Large Cell Lymphoma
    • Angioimmunoblastic T-cell Lymphoma
    • Nasal NK-Cell Lymphoma
    • Enteropathy-Associated T-cell Lymphoma
    • Hepatosplenic T-cell Lymphoma
    • Subcutaneous Panniculitis-Like T-cell Lymphoma
    • NK-Cell Leukemia
    • Adult T-cell Leukemia Lymphoma
  • Lymphoma Staging
  • Treatment Paradigms
    • General Principles
    • Transplant
    • Drugs
    • Clinical Trials
  • What is a Clinical Trial?

• For Medical Providers
  • Current PTCL Treatment Paradigms
  • References
  • Clinical Trials

Profiles

• Andrei Shustov - President & Founder
  
• Toni-Ann Lupinacci - Vice President & Co-Founder
  
• Sindhu Cherian - Director
  
• Jenna Lange - Director
  

Events Calendar

• Events Calendar

Client Testimonials

• Testimonials